Ulcerative Colitis Six Years After Colon Cancer: Only a Coincidence?

Overview

Journal Int Med Case Rep J

Publisher Dove Medical Press

Specialty General Medicine

Date 2014 May 24

PMID 24855393

Authors

Minas Sakellakis

Thomas Makatsoris

Maria Gkermpesi

Stavros Peroukidis

Haralabos Kalofonos

Affiliations

Soon will be listed here.

Abstract

The association between inflammatory bowel disease and colorectal cancer is well known. Ulcerative colitis is a risk factor for the development of colorectal cancer, and this risk increases with the activity and duration of bowel inflammation. Here we describe the case of a 52-year-old man who developed ulcerative colitis 6 years after the diagnosis and treatment of colon cancer. Although this could be a coincidence, there could be additional possibilities, like pre-existence of quiescent colitis, late effect of therapy, or maybe the existence of common pathogenetic factors contributing to the development of ulcerative colitis and colorectal cancer.

References

Ekbom A, HELMICK C, Zack M, Adami H . The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991; 100(2):350-8. DOI: 10.1016/0016-5085(91)90202-v. View

Katsanos K, Christodoulou D, Siozopoulou V, Eufimia B, Bali C, Fatouros M . Silent ulcerative colitis adjacent to a regular sigmoid adenocarcinoma. Eur J Gastroenterol Hepatol. 2011; 23(10):957-60. DOI: 10.1097/MEG.0b013e328348a605. View

Ando T, Nishio Y, Watanabe O, Takahashi H, Maeda O, Ishiguro K . Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis. World J Gastroenterol. 2008; 14(14):2133-8. PMC: 2703836. DOI: 10.3748/wjg.14.2133. View

Itzkowitz S, Yio X . Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004; 287(1):G7-17. DOI: 10.1152/ajpgi.00079.2004. View

Risques R, Lai L, Himmetoglu C, Ebaee A, Li L, Feng Z . Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res. 2011; 71(5):1669-79. PMC: 3077943. DOI: 10.1158/0008-5472.CAN-10-1966. View

Rhodes J, Campbell B . Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med. 2002; 8(1):10-6. DOI: 10.1016/s1471-4914(01)02194-3. View

Breynaert C, Vermeire S, Rutgeerts P, Van Assche G . Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?. Acta Gastroenterol Belg. 2009; 71(4):367-72. View

Ramsey S, Berry K, Moinpour C, Giedzinska A, Andersen M . Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol. 2002; 97(5):1228-34. DOI: 10.1111/j.1572-0241.2002.05694.x. View

Triantafillidis J, Nasioulas G, Kosmidis P . Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009; 29(7):2727-37. View

10.

Riley S, Mani V, GOODMAN M, Dutt S, Herd M . Microscopic activity in ulcerative colitis: what does it mean?. Gut. 1991; 32(2):174-8. PMC: 1378803. DOI: 10.1136/gut.32.2.174. View

11.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1):11-30. DOI: 10.3322/caac.21166. View

12.

Langan R, Gotsch P, Krafczyk M, Skillinge D . Ulcerative colitis: diagnosis and treatment. Am Fam Physician. 2007; 76(9):1323-30. View

13.

Ahmadi A, Polyak S, Draganov P . Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J Gastroenterol. 2008; 15(1):61-6. PMC: 2653296. DOI: 10.3748/wjg.15.61. View

14.

Danese S, Fiocchi C . Ulcerative colitis. N Engl J Med. 2011; 365(18):1713-25. DOI: 10.1056/NEJMra1102942. View

15.

Watson A, Collins P . Colon cancer: a civilization disorder. Dig Dis. 2011; 29(2):222-8. DOI: 10.1159/000323926. View